See more : Novac Co., Ltd. (5079.T) Income Statement Analysis – Financial Results
Complete financial analysis of Biofil Chemicals and Pharmaceuticals Limited (BIOFILCHEM.BO) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Biofil Chemicals and Pharmaceuticals Limited, a leading company in the Drug Manufacturers – Specialty & Generic industry within the Healthcare sector.
- Ollie’s Bargain Outlet Holdings, Inc. (OLLI) Income Statement Analysis – Financial Results
- United Community Banks, Inc. (UCBI) Income Statement Analysis – Financial Results
- Lumine Group Inc. (LMN.V) Income Statement Analysis – Financial Results
- Chilco River Holdings, Inc. (CRVH) Income Statement Analysis – Financial Results
- CLSA Premium Limited (6877.HK) Income Statement Analysis – Financial Results
Biofil Chemicals and Pharmaceuticals Limited (BIOFILCHEM.BO)
Industry: Drug Manufacturers - Specialty & Generic
Sector: Healthcare
Website: https://www.biofilgroup.net
About Biofil Chemicals and Pharmaceuticals Limited
Biofil Chemicals and Pharmaceuticals Limited engages in the pharmaceutical and chemical businesses primarily in India. The company offers basic drugs and chemicals, such as sodium chloride, potassium chloride, sodium citrate, diethyl carbamazine citrate, ferrous sulphate, dried ferrous sulphate, ferrous fumerate, micro crystalline cellulose, and dicyclomine hydrochloride; and plastic dippers and caps. It also provides job work service for manufacturing of pharmaceuticals. Biofil Chemicals and Pharmaceuticals Limited was incorporated in 1985 and is based in Indore, India.
| Metric | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 400.35M | 300.35M | 223.82M | 357.50M | 296.90M | 231.29M | 123.60M | 134.54M | 131.72M | 58.62M | 71.72M | 60.11M | 62.74M | 21.52M | 17.57M | 13.53M | 8.79M |
| Cost of Revenue | 375.08M | 278.97M | 198.75M | 324.27M | 253.09M | 199.93M | 97.71M | 85.11M | 113.78M | 43.87M | 52.79M | 42.85M | 52.56M | 19.65M | 16.35M | 9.99M | 5.92M |
| Gross Profit | 25.28M | 21.38M | 25.07M | 33.24M | 43.81M | 31.36M | 25.89M | 49.43M | 17.94M | 14.75M | 18.92M | 17.26M | 10.18M | 1.87M | 1.22M | 3.54M | 2.88M |
| Gross Profit Ratio | 6.31% | 7.12% | 11.20% | 9.30% | 14.76% | 13.56% | 20.95% | 36.74% | 13.62% | 25.16% | 26.39% | 28.71% | 16.23% | 8.70% | 6.94% | 26.17% | 32.69% |
| Research & Development | 0.00 | 0.00 | 0.00 | 104.00K | 224.00K | 118.00K | 46.00K | 40.00K | 30.00K | 3.13K | 9.05K | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| General & Administrative | 1.40M | 2.95M | 3.49M | 1.76M | 1.30M | 849.00K | 2.55M | 2.32M | 1.42M | 720.63K | 1.86M | 2.45M | 2.14M | 9.57M | 0.00 | 0.00 | 0.00 |
| Selling & Marketing | 116.00K | 521.00K | 392.00K | 86.00K | 3.82M | 3.88M | 377.00K | 3.11M | 648.26K | 4.34K | 3.26M | 363.47K | 121.40K | 118.01K | 3.93M | 3.68M | 0.00 |
| SG&A | 1.52M | 3.47M | 3.88M | 1.85M | 5.12M | 4.73M | 2.93M | 5.43M | 2.07M | 724.98K | 5.13M | 2.81M | 2.26M | 9.69M | 3.93M | 3.68M | 0.00 |
| Other Expenses | 0.00 | 970.00K | 1.50M | 7.76M | 1.50M | 799.00K | 704.00K | 1.11M | 420.00K | 4.59M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Operating Expenses | 16.21M | 14.00M | 16.02M | 21.36M | 29.66M | 24.78M | 19.49M | 26.07M | 7.25M | 9.92M | 10.94M | 8.65M | 7.74M | -8.13M | -4.26M | 7.37M | 6.71M |
| Cost & Expenses | 391.28M | 292.97M | 214.77M | 345.63M | 282.75M | 224.70M | 117.20M | 111.18M | 121.03M | 53.79M | 63.73M | 51.50M | 60.30M | 11.52M | 12.09M | 17.36M | 12.62M |
| Interest Income | 67.00K | 16.00K | 210.00K | 214.00K | 216.00K | 214.00K | 303.00K | 269.00K | 218.24K | 29.69K | 57.42K | 7.58K | 549.00 | -27.35K | -7.46K | -19.60K | -4.24K |
| Interest Expense | 415.00K | 425.00K | 406.00K | 642.00K | 1.21M | 1.60M | 1.51M | 1.63M | 1.51M | 2.08M | 1.51M | 1.92M | 827.40K | 63.87K | 25.22K | 110.27K | 2.82M |
| Depreciation & Amortization | 3.99M | 4.29M | 4.28M | 4.12M | 4.08M | 3.65M | 2.96M | 2.84M | 2.69M | 2.66M | 2.38M | 2.27M | 2.07M | 1.70M | 1.07M | 1.09M | 1.09M |
| EBITDA | 13.06M | 12.65M | 14.83M | 23.99M | 19.95M | 11.25M | 10.37M | 27.58M | 14.01M | 11.96M | 10.40M | 10.72M | 4.51M | 11.70M | 6.55M | -2.75M | -2.74M |
| EBITDA Ratio | 3.26% | 4.21% | 6.63% | 6.69% | 6.80% | 4.86% | 8.37% | 20.50% | 10.63% | 20.64% | 14.50% | 18.10% | 7.19% | 54.37% | 37.31% | -30.20% | -31.13% |
| Operating Income | 9.07M | 7.39M | 9.05M | 11.87M | 14.15M | 6.59M | 6.40M | 23.36M | 6.06M | 9.44M | 8.01M | 8.61M | 2.44M | 10.01M | 5.48M | -5.17M | -3.83M |
| Operating Income Ratio | 2.27% | 2.46% | 4.04% | 3.32% | 4.77% | 2.85% | 5.18% | 17.36% | 4.60% | 16.10% | 11.17% | 14.32% | 3.89% | 46.49% | 31.20% | -38.23% | -43.55% |
| Total Other Income/Expenses | -415.70K | -410.00K | 1.10M | 7.32M | 491.00K | -602.00K | -515.00K | -1.36M | -881.00K | -2.08M | -1.48M | -1.91M | -830.44K | -91.21K | -32.69K | 1.21M | -2.82M |
| Income Before Tax | 8.65M | 7.93M | 10.15M | 19.19M | 14.64M | 5.98M | 5.88M | 23.10M | 9.81M | 7.35M | 6.51M | 6.70M | 1.61M | 9.91M | 5.45M | -2.62M | -6.65M |
| Income Before Tax Ratio | 2.16% | 2.64% | 4.53% | 5.37% | 4.93% | 2.59% | 4.76% | 17.17% | 7.45% | 12.55% | 9.07% | 11.15% | 2.56% | 46.07% | 31.01% | -19.36% | -75.62% |
| Income Tax Expense | 1.56M | 2.33M | 3.17M | 6.78M | 2.57M | 1.16M | 1.18M | 5.16M | 1.98M | 1.48M | 1.34M | 1.28M | 103.70K | -4.42K | 0.00 | 12.00K | 25.00K |
| Net Income | 7.09M | 5.60M | 6.98M | 12.41M | 12.07M | 4.82M | 4.71M | 17.94M | 7.83M | 5.87M | 5.17M | 5.42M | 1.51M | 9.92M | 5.45M | -2.63M | -6.68M |
| Net Income Ratio | 1.77% | 1.87% | 3.12% | 3.47% | 4.07% | 2.09% | 3.81% | 13.34% | 5.94% | 10.02% | 7.20% | 9.02% | 2.40% | 46.09% | 31.01% | -19.45% | -75.90% |
| EPS | 0.44 | 0.34 | 0.43 | 0.76 | 0.74 | 0.30 | 0.29 | 1.10 | 0.48 | 0.36 | 0.32 | 0.33 | 0.09 | 0.61 | 0.52 | -0.25 | -0.06 |
| EPS Diluted | 0.44 | 0.34 | 0.43 | 0.76 | 0.74 | 0.30 | 0.29 | 1.10 | 0.48 | 0.36 | 0.32 | 0.33 | 0.09 | 0.61 | 0.52 | -0.25 | -0.06 |
| Weighted Avg Shares Out | 16.12M | 16.27M | 16.27M | 16.27M | 16.27M | 16.27M | 16.27M | 16.27M | 16.27M | 16.27M | 16.27M | 16.27M | 16.27M | 16.27M | 10.56M | 10.56M | 105.95M |
| Weighted Avg Shares Out (Dil) | 16.12M | 16.27M | 16.27M | 16.27M | 16.27M | 16.27M | 16.27M | 16.27M | 16.27M | 16.27M | 16.27M | 16.27M | 16.27M | 16.27M | 10.56M | 10.56M | 105.95M |
Source: https://incomestatements.info
Category: Stock Reports